title: Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers.
abstract: The use of fluorodeoxyglucose positron emission tomography (FDG PET) scan technology in the management of head and neck cancers continues to increase. We discuss the biology of FDG uptake in malignant lesions and also discuss the physics of PET imaging. The various parameters described to quantify FDG uptake in cancers including standardized uptake value, metabolic tumor volume and total lesion glycolysis are presented. PET scans have found a significant role in the diagnosis and staging of head and neck cancers. They are also being increasingly used in radiation therapy treatment planning. Many groups have also used PET derived values to serve as prognostic indicators of outcomes including loco-regional control and overall survival. FDG PET scans are also proving very useful in assessing the efficacy of treatment and management and follow-up of head and neck cancer patients. This review article focuses on the role of FDG-PET computed tomography scans in these areas for squamous cell carcinoma of the head and neck. We present the current state of the art and speculate on the future applications of this technology including protocol development, newer imaging methods such as combined magnetic resonance and PET imaging and novel radiopharmaceuticals that can be used to further study tumor biology.
authors: Farzan Siddiqui, Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, United States.
authors: Farzan
authors: F
authors: Siddiqui
authors: Farzan Siddiqui, Department of Radiation Oncology, Henry Ford Health System, Detroit, MI 48202, United States.
authors: Min
authors: M
authors: Yao
keywords: Fluorodeoxyglucose; Head and neck cancer; Positron emission tomography; Radiation therapy planning; Squamous cell carcinoma